UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 175

Sortiert nach

Cannabis use and psychosis: a review of reviews

European archives of psychiatry and clinical neuroscience, 2020-06, Vol.270 (4), p.403-412

2020

Link zum Volltext

Verfügbarkeit prüfen

Anandamide dysfunction in prodromal and established psychosis

Current pharmaceutical design, 2012-11, Vol.18 (32), p.5188

Leweke, F Markus

2012

Link zum Volltext

Verfügbarkeit prüfen

Right care, first time: a highly personalised and measurement‐based care model to manage youth mental health

Medical journal of Australia, 2019-11, Vol.211 (S9), p.S3-S46

2019

Link zum Volltext

Verfügbarkeit prüfen

Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia

Schizophrenia research, 2013-08, Vol.148 (1), p.130-137

2013

Link zum Volltext

Verfügbarkeit prüfen

Resting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages

eLife, 2018-09, Vol.7

2018

Link zum Volltext

Verfügbarkeit prüfen

Obituary for Professor Hinderk Meiners Emrich, MD PhD

European archives of psychiatry and clinical neuroscience, 2018-12, Vol.268 (8), p.873-874

2018

Link zum Volltext

Verfügbarkeit prüfen

Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial

Frontiers in pharmacology, 2021-04, Vol.12, p.614811-614811

2021

Link zum Volltext

Verfügbarkeit prüfen

Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state

Frontiers in psychiatry, 2023-03, Vol.14, p.1088459

2023

Link zum Volltext

Verfügbarkeit prüfen

Evidence for dysregulated high-frequency oscillations during sensory processing in medication-naïve, first episode schizophrenia

Schizophrenia research, 2013-11, Vol.150 (2), p.519-525

2013

Link zum Volltext

Verfügbarkeit prüfen

Different pharmaceutical preparations of Δ9‐tetrahydrocannabinol differentially affect its behavioral effects in rats

Addiction biology, 2020-05, Vol.25 (3), p.e12745-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Current State of Fluid Lipid Biomarkers for Personalized Diagnostics and Therapeutics in Schizophrenia Spectrum Disorders and Related Psychoses: A Narrative Review

Frontiers in psychiatry, 2022-05, Vol.13, p.885904-885904

2022

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms

Neuropsychopharmacology, 2004-11, Vol.29 (11), p.2108-2114

2004

Link zum Volltext

Verfügbarkeit prüfen

Distinct molecular phenotypes in male and female schizophrenia patients

PloS one, 2013-11, Vol.8 (11), p.e78729-e78729

2013

Link zum Volltext

Verfügbarkeit prüfen

ReTimeML: a retention time predictor that supports the LC-MS/MS analysis of sphingolipids

Scientific reports, 2024-02, Vol.14 (1), p.4375-4375

2024

Link zum Volltext

Verfügbarkeit prüfen

Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention

CNS drugs, 2018-07, Vol.32 (7), p.605-619

2018

Link zum Volltext

Verfügbarkeit prüfen

Neural correlates of binocular depth inversion illusion in antipsychotic-naïve first-episode schizophrenia patients

European archives of psychiatry and clinical neuroscience, 2019-12, Vol.269 (8), p.897-910

2019

Link zum Volltext

Verfügbarkeit prüfen

Reduced superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with early psychosis in association with clinical features

Schizophrenia research, 2017-05, Vol.183, p.64-69

2017

Link zum Volltext

Verfügbarkeit prüfen

Effects of adjunctive brexpiprazole on sleep-wake and circadian parameters in youth with depressive disorders: study protocol for a clinical trial

BMJ open, 2022-09, Vol.12 (9), p.e056298-e056298

2022

Link zum Volltext

Verfügbarkeit prüfen

Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers

Frontiers in psychiatry, 2021-03, Vol.12, p.654602-654602

2021

Link zum Volltext

Verfügbarkeit prüfen

Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis

British journal of psychiatry, 2009-04, Vol.194 (4), p.371-372

2009

Link zum Volltext

Verfügbarkeit prüfen

The Functional Networks of Prepulse Inhibition: Neuronal Connectivity Analysis Based on FDG-PET in Awake and Unrestrained Rats

Frontiers in behavioral neuroscience, 2016-07, Vol.10, p.148-148

2016

Link zum Volltext

Verfügbarkeit prüfen

Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: Impact of cannabis use

Schizophrenia research, 2007-08, Vol.94 (1), p.29-36

2007

Link zum Volltext

Verfügbarkeit prüfen

IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia

Brain, behavior, and immunity, 2015-02, Vol.44, p.148-158

2015

Link zum Volltext

Verfügbarkeit prüfen

Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia

PLoS medicine, 2006-08, Vol.3 (8), p.e327-e327

2006

Link zum Volltext

Verfügbarkeit prüfen

Plasma endocannabinoids in cocaine dependence and their relation to cerebral metabotropic glutamate receptor 5 density

Translational psychiatry, 2023-10, Vol.13 (1), p.325-325, Article 325

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 175

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(163)
Mit Volltextzugriff
(152)

Publikationsform

Sprache

Englisch
(161)
Japanisch
(20)
Deutsch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(119)
Life Sciences & Biomedicine
(107)
Humans
(97)
Psychiatry
(87)
Male
(71)
Schizophrenia
(67)
Female
(64)
Adult
(63)
Neurosciences & Neurology
(40)
Neurosciences
(37)
Young Adult
(33)
Biological And Medical Sciences
(31)
Medical Sciences
(29)
Middle Aged
(23)
Psychoses
(23)
Pharmacology & Pharmacy
(22)
Clinical Neurology
(21)
Psychology. Psychoanalysis. Psychiatry
(21)
Psychosis
(21)
Adult And Adolescent Clinical Studies
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cannabis use and psychosis: a review of reviews

Anandamide dysfunction in prodromal and established psychosis

Right care, first time: a highly personalised and measurement‐based care model to manage youth mental health

Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia

Resting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages

Obituary for Professor Hinderk Meiners Emrich, MD PhD

Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial

Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state

Evidence for dysregulated high-frequency oscillations during sensory processing in medication-naïve, first episode schizophrenia

Different pharmaceutical preparations of Δ9‐tetrahydrocannabinol differentially affect its behavioral effects in rats

Current State of Fluid Lipid Biomarkers for Personalized Diagnostics and Therapeutics in Schizophrenia Spectrum Disorders and Related Psychoses: A Narrative Review

Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms

Distinct molecular phenotypes in male and female schizophrenia patients

ReTimeML: a retention time predictor that supports the LC-MS/MS analysis of sphingolipids

Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention

Neural correlates of binocular depth inversion illusion in antipsychotic-naïve first-episode schizophrenia patients

Reduced superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with early psychosis in association with clinical features

Effects of adjunctive brexpiprazole on sleep-wake and circadian parameters in youth with depressive disorders: study protocol for a clinical trial

Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers

Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis

The Functional Networks of Prepulse Inhibition: Neuronal Connectivity Analysis Based on FDG-PET in Awake and Unrestrained Rats

Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: Impact of cannabis use

IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia

Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia

Plasma endocannabinoids in cocaine dependence and their relation to cerebral metabotropic glutamate receptor 5 density

Suchergebnisse filtern